Moreover, these studies imply not only that the loss of RB1 may divert mesenchymal stem cells away from the osteoblastic lineage or induce their dedifferentiation but also suggest that RB1 holds therapeutic significance for bone and metabolic disorders. This evidence concerns the gene RB1 and metabolic disease.